Happily, Paris is a conservative city, slow-changing and resistant to "progress," and quite a few of the genuine articles survive.
I read about some people who made this work in Harlem, so it's obviously the answer for Haitians, whom through newspaper reading, I have deduced are also resistant to progress.Mr Brooks's problem here is an overly credulous embrace of what the development world calls "best practices".
In fact, no aspect of American life has appeared more resistant to racial progress than the criminal-justice system.
Like most, I assumed they were cult-addled nuts, resistant to the progress of science and inexplicably in competition with one another for a spot on heaven's coveted 144,000-person roster.
First, the model shows that shorter lengths of antibiotic therapy and early interruption of antibiotic therapy provide an advantage for the resistant strains and result in infections caused by these resistant bacteria to progress.
(1) Most patients are initially responsive to androgen-deprivation therapy (ADT), but their cancers eventually become resistant to ADT and progress to castration-resistant prostate cancer (CRPC).
Zaltrap was approved by FDA in August 2012, for the treatment of metastatic colorectal carcinoma that is resistant to or has progressed following an oxiplatin-containing regimen.
Most surprisingly, they excluded from their analysis the pivotal, randomized, VELOUR trial, in patients with mCRC who were resistant to or had progressed on a prior oxaliplatin-containing regimen [ 3], which led to the only approved indication for aflibercept.
Cases that have severe exudative changes in the retina are often resistant to laser therapy and progress to an advanced level of subretinal exudation or fibrosis, which necessitates cryotherapy with surgical drainage of sub-retinal fluid (SRF) or pars plana vitrectomy [ 3].
About half of the ERα-positive breast tumours completely fail to respond (intrinsic resistance), whereas all responsive breast cancers ultimately progress and become resistant to the treatment (acquired resistance).
A new option for patients with mCRC resistant to or that has progressed following an oxaliplatin-containing regimen is aflibercept (ziv-aflibercept in the United States), a novel fusion protein that acts as a soluble receptor that binds to VEGF-A, VEGF-B and placental growth factor, added to FOLFIRI.
